ArticleJournal of Cancer2024

High Expression of RAB32 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioblastoma.

Liji Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.